Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Sexually Transmitted Diseases

  Free Subscription


1 Br J Cancer
3 Gynecol Oncol
1 Infect Immun
1 Int J Cancer
1 J Clin Microbiol
1 J Med Microbiol
1 J Virol
2 Lancet Glob Health
1 Lancet Oncol
1 N Engl J Med
2 PLoS One
1 Sex Transm Dis
1 Sex Transm Infect

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. LEI J, Andrae B, Ploner A, Lagheden C, et al
    Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study.
    BMJ. 2019;365:l1207.
    PubMed     Text format     Abstract available

  2. WISE J
    DIY smear tests: are they the answer to falling cervical screening rates?
    BMJ. 2019;364:l361.
    PubMed     Text format    

    Br J Cancer

  3. HORN J, Denecke A, Luyten A, Rothe B, et al
    Reduction of cervical cancer incidence within a primary HPV screening pilot project (WOLPHSCREEN) in Wolfsburg, Germany.
    Br J Cancer. 2019 Apr 16. pii: 10.1038/s41416-019-0453.
    PubMed     Text format     Abstract available

    Gynecol Oncol

  4. GIULIANO AR, Joura EA, Garland SM, Huh WK, et al
    Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population.
    Gynecol Oncol. 2019 Apr 11. pii: S0090-8258(19)30488.
    PubMed     Text format     Abstract available

  5. ZHANG L, Jiang Y, Lu X, Zhao H, et al
    Genomic characterization of cervical cancer based on human papillomavirus status.
    Gynecol Oncol. 2018 Dec 20. pii: S0090-8258(18)31516.
    PubMed     Text format     Abstract available

  6. VELENTZIS LS, Smith MA, Simms KT, Lew JB, et al
    Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia.
    Gynecol Oncol. 2019;152:465-471.
    PubMed     Text format     Abstract available

    Infect Immun

  7. HELBLE JD, Starnbach MN
    A Chlamydia trachomatis strain expressing OVA stimulates an antigen-specific CD4(+) T cell response in mice.
    Infect Immun. 2019 Apr 15. pii: IAI.00837-18. doi: 10.1128/IAI.00837.
    PubMed     Text format     Abstract available

    Int J Cancer

  8. LEEMAN A, Del Pino M, Marimon L, Torne A, et al
    Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
    Int J Cancer. 2019;144:160-168.
    PubMed     Text format     Abstract available

    Int J STD AIDS

  9. ALCEDO S, Newby R, Jose Montenegro J, Rondan P, et al
    Immune reconstitution inflammatory syndrome associated with secondary syphilis: dermatologic, neurologic and ophthalmologic compromise in an HIV patient.
    Int J STD AIDS. 2019;30:509-511.
    PubMed     Text format     Abstract available

  10. DE FRANCESCO D, Winston A, Underwood J, Cresswell FV, et al
    Cognitive function, depressive symptoms and syphilis in HIV-positive and HIV-negative individuals.
    Int J STD AIDS. 2019;30:440-446.
    PubMed     Text format     Abstract available

    J Clin Microbiol

  11. UPRETY P, Cardenas AM
    Extragenital Screening is Essential for Comprehensive Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in the Pediatric Population.
    J Clin Microbiol. 2019 Apr 17. pii: JCM.00335-19. doi: 10.1128/JCM.00335.
    PubMed     Text format     Abstract available

    J Med Microbiol

  12. MEFFRAY A, Perrin M, Richier A, Schmitt A, et al
    Molecular detection of Treponema pallidum subspecies pallidum in 150-year-old foetal remains, southeastern France.
    J Med Microbiol. 2019 Apr 17. doi: 10.1099/jmm.0.000978.
    PubMed     Text format     Abstract available

    J Virol

  13. BRONIARCZYK J, Massimi P, Pim D, Bergant Marusic M, et al
    Phosphorylation of HPV-16 L2 Contributes To Efficient Virus Infectious Entry.
    J Virol. 2019 Apr 17. pii: JVI.00128-19. doi: 10.1128/JVI.00128.
    PubMed     Text format     Abstract available

    Lancet Glob Health

  14. CHIDO-AMAJUOYI OG, Domgue JF, Obi-Jeff C, Schmeler K, et al
    Gender-neutral HPV vaccination in Africa - Authors' reply.
    Lancet Glob Health. 2019;7:e564.
    PubMed     Text format    

  15. ZHUANG RY, Goyal H, Xu HG
    Gender-neutral HPV vaccination in Africa.
    Lancet Glob Health. 2019;7:e563.
    PubMed     Text format    

    Lancet Oncol

  16. BURKI TK
    Therapeutic HPV vaccine for cervical intraepithelial neoplasia.
    Lancet Oncol. 2019 Apr 12. pii: S1470-2045(19)30224.
    PubMed     Text format    

    N Engl J Med

  17. FLOREZ-POLLACK S, Mauskar MM
    Disseminated Gonococcal Infection.
    N Engl J Med. 2019;380:1565.
    PubMed     Text format    

    PLoS One

  18. WIJERS JNAP, Hoebe CJPA, van Liere GAFS, Wolffs PFG, et al
    Chlamydia trachomatis bacterial load, estimated by Cq values, in urogenital samples from men and women visiting the general practice, hospital or STI clinic.
    PLoS One. 2019;14:e0215606.
    PubMed     Text format     Abstract available

  19. PHILLIPS S, Robbins A, Loader J, Hanger J, et al
    Chlamydia pecorum gastrointestinal tract infection associations with urogenital tract infections in the koala (Phascolarctos cinereus).
    PLoS One. 2018;13:e0206471.
    PubMed     Text format     Abstract available

    Sex Transm Dis

  20. LORETAN C, Chamberlain AT, Sanchez T, Zlotorzynska M, et al
    Trends and Characteristics Associated with HPV Vaccination Uptake Among Men Who Have Sex with Men in the United States, 2014 - 2017.
    Sex Transm Dis. 2019 Apr 15. doi: 10.1097/OLQ.0000000000001008.
    PubMed     Text format     Abstract available

    Sex Transm Infect

  21. REGAN DG, Hui BB, Guy RJ, Donovan B, et al
    Supplemental Trichomonas vaginalis testing is required to maintain control following a transition from Pap smear to HPV DNA testing for cervical screening: a mathematical modelling study.
    Sex Transm Infect. 2019 Apr 16. pii: sextrans-2018-053845.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.